{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:14:57Z","timestamp":1770992097078,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41575-020-0312-x","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T09:19:40Z","timestamp":1589361580000},"page":"444-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["COVID-19 and endoscopy: implications for healthcare and digestive cancer screening"],"prefix":"10.1038","volume":"17","author":[{"given":"Ian M.","family":"Gralnek","sequence":"first","affiliation":[]},{"given":"Cesare","family":"Hassan","sequence":"additional","affiliation":[]},{"given":"Mario","family":"Dinis-Ribeiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"312_CR1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1155-6229","author":"IM Gralnek","year":"2020","unstructured":"Gralnek, I. M. et al. ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy https:\/\/doi.org\/10.1055\/a-1155-6229 (2020).","journal-title":"Endoscopy"},{"key":"312_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2020.03.019","author":"A Repici","year":"2020","unstructured":"Repici, A. et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest. Endosc. https:\/\/doi.org\/10.1016\/j.gie.2020.03.019 (2020).","journal-title":"Gastrointest. Endosc."},{"key":"312_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1055\/a-1104-5245","volume":"52","author":"A S\u0103ftoiu","year":"2020","unstructured":"S\u0103ftoiu, A. et al. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 52, 293\u2013304 (2020).","journal-title":"Endoscopy"},{"key":"312_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1055\/s-0032-1325969","volume":"45","author":"European Colorectal Cancer Screening Guidelines Working Group","year":"2013","unstructured":"European Colorectal Cancer Screening Guidelines Working Group. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 45, 51\u201359 (2013).","journal-title":"Endoscopy"},{"key":"312_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cgh.2018.10.041","volume":"17","author":"YC Lee","year":"2019","unstructured":"Lee, Y. C. et al. Time to colonoscopy and risk of colorectal cancer in patients with positive results from fecal immunochemical tests. Clin. Gastroenterol. Hepatol. 17, 1332\u20131340 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"312_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"P Pimentel-Nunes","year":"2019","unstructured":"Pimentel-Nunes, P. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 51, 365\u2013388 (2019).","journal-title":"Endoscopy"},{"key":"312_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/2050640617722902","volume":"6","author":"M Areia","year":"2018","unstructured":"Areia, M., Spaander, M. C. & Kuipers, E. J. et al. Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk. United European Gastroenterol. J. 6, 192\u2013202 (2018).","journal-title":"United European Gastroenterol. J."},{"key":"312_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-320036","author":"AJ Cross","year":"2020","unstructured":"Cross, A. J. et al. Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study. Gut https:\/\/doi.org\/10.1136\/gutjnl-2019-320036 (2020).","journal-title":"Gut"},{"key":"312_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/a-0831-2522","volume":"51","author":"C Hassan","year":"2019","unstructured":"Hassan, C. et al. Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline. Endoscopy 51, 266\u2013277 (2019).","journal-title":"Endoscopy"},{"key":"312_CR10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1053\/j.gastro.2018.12.006","volume":"156","author":"L Fuccio","year":"2019","unstructured":"Fuccio, L. et al. New and recurrent colorectal cancers after resection: a systematic review and meta-analysis of endoscopic surveillance studies. Gastroenterology 156, 1309\u20131323 (2019).","journal-title":"Gastroenterology"}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41575-020-0312-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41575-020-0312-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41575-020-0312-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:52:53Z","timestamp":1684619573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-020-0312-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["312"],"URL":"https:\/\/doi.org\/10.1038\/s41575-020-0312-x","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"13 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.M.G. has received lecture fees from Astra-Zeneca, Taro Pharma, Vifor Pharma and 3D Matrix. He is also a paid consultant for Boston Scientific, GI View, Motus GI and Symbionix and is a member of the medical advisory board of Motus GI. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}